Filing Flows › ProPhase Labs (PRPH) › Q2 2026 › vs Q2 2025
ProPhase Labs (PRPH) Q2 2026 vs Q2 2025 (year over year)
ProPhase Labs's revenue fell $236K (-19%) from $1.2M in Q2 2025 to $1.0M in Q2 2026.
ProPhase Labs, Q2 2026: revenue $1.0M (-19% year over year), operating margin -261.6%, net loss $3.1M, operating cash flow −$78K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.0M | $1.2M | −$236K | -19% |
| Net loss | $3.1M | $4.5M | −$1.4M | -32% |
| Costs & expenses | $4.1M | $5.9M | −$1.9M | -31% |
| Operating costs | $3.7M | $5.1M | −$1.5M | -29% |
| Interest & other, net | $394K | −$201K | $595K | — |
| Income tax | $12K | $779K | −$767K | -98% |
| Cost of revenue | $785K | $513K | $272K | +53% |
| Operating expenses | $2.9M | $4.6M | −$1.8M | -38% |
| Operating cash sources | $3.1M | $4.5M | −$1.4M | -32% |
| Depreciation & amortization | $963K | $1.3M | −$386K | -29% |
| Share-based compensation | $375K | $508K | −$133K | -26% |
| Working capital & other | $1.6M | $2.4M | −$733K | -31% |
| Cash used in operations | $78K | $247K | −$169K | -68% |
| Net loss absorbed | $3.1M | $4.5M | −$1.4M | -32% |
Questions
How much did ProPhase Labs's revenue grow year over year in Q2 2026?
ProPhase Labs's revenue fell $236K (-19%) from $1.2M in Q2 2025 to $1.0M in Q2 2026.